ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 46 Issue 3       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Acta Oncologica, Volume 46 Issue 3 2007

Acta Oncologica is moving!


2008 Impact Factor: 2.739 (ISI Web of Knowledge, 2008 Journal Citation Report)
Online content older than 6 months is available for full text dowload
ISSN: 1651-226X (electronic) 0284-186X (paper)
Publication Frequency: 8 issues per year
Subject: Oncology;
You have: FREE ACCESS FREE ACCESS
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2Next >
select-down Click for help
REVIEW ARTICLE
Advances in the treatment of patients with gastric adenocarcinoma
Theodoros Foukakis;  Lars Lundell;  Michael Gubanski; Pehr A. Lind
Pages 277 – 285
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
ORIGINAL ARTICLE
Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers
Eero Pukkala;  Aage Andersen;  Göran Berglund;  Randi Gislefoss;  Vilmundur Gudnason;  Göran Hallmans;  Egil Jellum;  Pekka Jousilahti;  Paul Knekt;  Pentti Koskela;  P. Pentti Kyyrönen;  Per Lenner;  Tapio Luostarinen;  Arthur Löve;  Helga Ögmundsdóttir;  Pär Stattin;  Leena Tenkanen;  Laufey Tryggvadóttir;  Jarmo Virtamo;  Göran Wadell;  Anders Widell;  Matti Lehtinen; Joakim Dillner
Pages 286 – 307
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years
Elisabeth Lello;  Bjørg Furnes; Tom-H. Edna
Pages 308 – 315
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: Relation to survival
O. Kurtenkov;  K. Klaamas;  S. Mensdorff-Pouilly;  L. Miljukhina;  L. Shljapnikova; V. Chužmarov
Pages 316 – 323
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles
Free Online Access FREE
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer
Efraim Idelevich;  Natalie Karminsky;  Michael Dinerman;  Rivka L. Katsenelson;  Nana Ben Zvi;  Noa Ben Baruch;  Haim Biran;  Sofia Man; Adi Shani
Pages 324 – 329
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Phase I study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first line therapy in patients with non-resectable gastric cancer
Jeanette Dupont;  Helle A. Jensen;  Benny V. Jensen; Per Pfeiffer
Pages 330 – 335
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer
Sung Yong Oh;  Hyuk-Chan Kwon;  Bong-Gun Seo;  Sung-Hyun Kim;  Jae-Seok Kim; Hyo-Jin Kim
Pages 336 – 341
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Diet and vitamin or mineral supplementation and risk of rectal cancer in Canada
Jinfu Hu;  Les Mery;  Marie Desmeules;  Monica MacLeod; The Canadian Cancer Registries Epidemiology Research Group
Pages 342 – 354
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles
Free Online Access FREE
Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas)
Ole Dan Jørgensen;  Ole Kronborg;  Claus Fenger; Morten Rasmussen
Pages 355 – 360
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer
Ji-Hong Pan;  Jin-Xiang Han;  Jian-Mei Wu;  Li-Jun Sheng; Hai-Nan Huang
Pages 361 – 366
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel
Oscar Juan;  Ana Albert;  Juan M. Campos;  Vicente Caranyana;  José Muñoz; Vicente Alberola
Pages 367 – 373
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer
Susanne Larsen;  Eva Serup-Hansen;  Lisbeth J. Andersen;  Birgit Lindeløv;  Tine McCulloch;  Parvin Adimi; Lars Bastholt
Pages 374 – 377
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: Potential for drug target
Kanlayanee Sawanyawisuth;  Chaisiri Wongkham;  Chawalit Pairojkul;  O-Tur Saeseow;  Gregory J. Riggins;  Norie Araki; Sopit Wongkham
Pages 378 – 385
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT
G. Studer;  U. M. Lütolf;  M. El-Bassiouni;  V. Rousson; C. Glanzmann
Pages 386 – 394
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
LETTER TO THE EDITOR
Fractionation sensitivity and equivalent doses. Commenting on the editorial by Glimelius
Adel Courdi
Pages 395 – 396
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles
Free Online Access FREE
In reply to Dr Courdi
Biologically equivalent doses (in 2 Gy/fr) to 5×5 Gy

Bengt Glimelius; Ulf Isacsson
Page 396
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
Free Online Access FREE
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文(简体和繁體)
© 2009 Informa plc